StockData
GSK plc logo

GSK plc (GSK) shareholders

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 9/30
$48.58−0.66 (-1.34%)

Close on Nov 18, 2026Market cap $104.82BP/E 13.2Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
347M
Shares held, 13F filers
Institutional holders
1,036
108 new, 81 sold out
Net institutional buying
-27M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.369,576,1148.90%13G (passive) amendmentDec 31, 2024
Abigail P. Johnson
Joint filing with FMR LLC (5.80%)
234,936,0615.80%13G (passive)Mar 31, 2026
GSK plc1,983,0259.50%13D (active) amendmentNov 12, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of GSKValueChange% of portfolio
FMR LLC64,961,641–$3.41B−2,700,0050.15%
Dodge & Cox48,197,514–$2.53B−10,465,4601.32%
Fisher Asset Management, LLC35,722,792–$1.87B+1,200,4290.56%
Primecap Management Co/Ca/25,182,068–$1.32B−22,4700.78%
Wellington Management Group Llp11,396,249–$597.39M−321,3640.10%
JTC Employer Solutions Trustee Ltd8,592,987–$450.32M−449,40236.11%
Morgan Stanley7,657,562–$401.41M−3,373,0890.02%
Royal Bank of Canada7,588,928–$397.81M+82,1420.06%
Price T Rowe Associates Inc /Md/6,923,642–$362.94M−399,1910.04%
Acadian Asset Management LLC6,660,434–$349.11M−5,136,6510.41%
Goldman Sachs Group Inc6,371,442–$333.99M−3,217,6720.03%
State Street Corp5,959,115–$315.14M−39,3710.01%
Mondrian Investment Partners LTD4,910,830–$257.43M−76,5633.97%
Bank Of Montreal /Can/4,042,863–$211.93M−596,9360.07%
BlackRock, Inc.3,620,294–$189.78M+69,3900.00%
Grantham, Mayo, Van Otterloo & Co. LLC3,599,521–$188.69M+76,9550.42%
Hotchkis & Wiley Capital Management LLC3,413,574–$178.94M−68,4800.52%
Equity Investment Corp3,269,765–$171.40M+48,7303.27%
UBS Group AG2,806,205–$147.10M+721,9700.02%
Connor, Clark & Lunn Investment Management Ltd.2,767,591–$145.08M−49,8540.27%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 20261,036347M108 / 376340 / 8117M44M
Q1 20261,031374M139 / 315382 / 8331M52M
Q4 2025993398M179 / 309338 / 6141M31M
Q3 2025892388M100 / 323307 / 7927M25M
Q2 2025887386M111 / 367252 / 6244M17M
Q1 2025854365M91 / 330277 / 6752M28M
Q4 2024844341M110 / 284317 / 14968M35M
Q3 2024894309M91 / 304319 / 6924M26M
Q2 2024879312M78 / 307304 / 8725M49M
Q1 2024901336M98 / 326298 / 7956M19M
Q4 2023889300M127 / 270341 / 6337M22M
Q3 2023842285M100 / 303268 / 7026M17M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

152 funds held GSK in Q2 2026, 3% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of GSKValue% of fundAs of
Dodge & Cox Stock Fund35,573,787–$1.86B1.58%Jun 30, 2026
Vanguard Primecap Fund18,172,650–$952.61M0.99%Jun 30, 2026
Vanguard Wellington Fund9,662,999–$488.37M0.39%May 31, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund7,787,127–$393.56M0.16%May 31, 2026
Fidelity Series Large Cap Stock Fund4,579,628–$240.06M0.83%Jun 30, 2026
Fidelity Series Value Discovery Fund4,136,200–$213.80M1.21%Jul 31, 2026
Dodge & Cox Balanced Fund3,600,595–$188.74M1.28%Jun 30, 2026
Vanguard Primecap Core Fund3,549,080–$186.04M1.03%Jun 30, 2026
Fidelity Growth and Income Portfolio3,439,475–$177.79M1.19%Jul 31, 2026
Fidelity Equity Dividend Income Fund2,665,900–$134.73M1.67%May 31, 2026
T. Rowe Price International Value Equity Fund2,639,571–$136.44M0.80%Jul 31, 2026
Select Pharmaceuticals Portfolio2,425,160–$122.57M8.17%May 31, 2026
Bridge Builder Large Cap Value Fund1,876,800–$98.38M0.34%Jun 30, 2026
Fidelity Large Cap Stock Fund1,708,759–$88.33M0.83%Jul 31, 2026
Vanguard Windsor Ii Fund1,597,215–$82.56M0.12%Jul 31, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
16M shares short
Days to cover
3.2
At 5M shares a day
Change since last report
+10.8%
From 15M shares
Short volume, 20 days
42.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of GSK's stock actually held short. Settlement fails (shares not delivered on time) peaked at 518,186 shares on Oct 9, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Martinez Maria E
Officer
Aug 20, 202644,397$2.31MAug 20, 2026Share Value Plan Vesting

Congress trades

40 trades in GSK reported by 10 members of the House

MemberTypeTradedAmountFiled
Lisa McClain
MI09 · spouse
SoldOct 31, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
SoldOct 30, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
BoughtOct 30, 2025$1K–15KNov 21, 2025
Valerie Hoyle
OR04 · spouse
SoldSep 23, 2025$1K–15KOct 10, 2025
Lisa McClain
MI09 · spouse
BoughtAug 4, 2025$1K–15KSep 12, 2025
Robert B. Aderholt
AL04
SoldJul 28, 2025$1K–15KSep 10, 2025
Lisa McClain
MI09 · spouse
SoldJun 24, 2025$1K–15KAug 13, 2025
50 days late
Lisa McClain
MI09 · spouse
BoughtJun 17, 2025$1K–15KAug 13, 2025
57 days late
Bruce Westerman
AR04
SoldApr 21, 2025$1K–15KMay 12, 2025
Bruce Westerman
AR04
BoughtMar 3, 2025$1K–15KApr 16, 2025
Marjorie Taylor Mrs Greene
GA14
BoughtNov 25, 2024$1K–15KNov 27, 2024
Valerie Hoyle
OR04 · spouse
BoughtNov 18, 2024$1K–15KSep 12, 2025
298 days late
Daniel Goldman
NY10
SoldJul 10, 2023$15K–50KAug 13, 2023
Virginia Foxx
NC05 · joint account
SoldMar 1, 2023$50K–100KApr 4, 2023
Virginia Foxx
NC05 · joint account
BoughtAug 16, 2022$1K–15KSep 8, 2022
Virginia Foxx
NC05 · joint account
BoughtAug 10, 2022$15K–50KSep 8, 2022
Virginia Foxx
NC05 · joint account
BoughtAug 9, 2022$1K–15KSep 8, 2022
Virginia Foxx
NC05 · joint account
BoughtAug 5, 2022$15K–50KSep 8, 2022
Virginia Foxx
NC05 · joint account
Sold (part)Jul 12, 2022$100K–250KAug 5, 2022
Virginia Foxx
NC05 · joint account
BoughtJul 6, 2022$1K–15KAug 5, 2022
Virginia Foxx
NC05 · joint account
BoughtApr 8, 2022$1K–15KMay 4, 2022
Virginia Foxx
NC05 · joint account
BoughtFeb 22, 2022$1K–15KMar 7, 2022
John Rutherford
FL05
SoldFeb 17, 2022$1K–15KMar 16, 2022
Virginia Foxx
NC05 · joint account
BoughtJan 14, 2022$1K–15KFeb 4, 2022
Virginia Foxx
NC05 · joint account
BoughtOct 8, 2021$1K–15KNov 2, 2021
Virginia Foxx
NC05 · joint account
BoughtJul 9, 2021$1K–15KAug 2, 2021
Katherine M. Clark
MA05 · spouse
SoldJun 4, 2021$1K–15KAug 15, 2021
72 days late
Katherine M. Clark
MA05 · spouse
SoldJun 4, 2021$1K–15KAug 15, 2021
72 days late
Virginia Foxx
NC05 · joint account
BoughtApr 9, 2021$1K–15KMay 5, 2021
Virginia Foxx
NC05 · joint account
BoughtJan 15, 2021$1K–15KFeb 1, 2021
Katherine M. Clark
MA05 · spouse
BoughtNov 5, 2020$1K–15KDec 28, 2020
53 days late
Katherine M. Clark
MA05 · spouse
BoughtNov 5, 2020$1K–15KDec 28, 2020
53 days late
Katherine M. Clark
MA05 · spouse
SoldOct 22, 2020$1K–15KDec 3, 2020
Katherine M. Clark
MA05 · spouse
SoldOct 22, 2020$1K–15KDec 3, 2020
Virginia Foxx
NC05 · joint account
BoughtOct 9, 2020$1K–15KNov 6, 2020
Virginia Foxx
NC05 · joint account
BoughtJul 10, 2020$1K–15KAug 10, 2020
Virginia Foxx
NC05 · joint account
BoughtApr 13, 2020$15KMay 4, 2020
Greg Gianforte
MT00 · joint account
BoughtMar 18, 2020$50KApr 7, 2020
Katherine M. Clark
MA05 · spouse
BoughtMar 2, 2020$1K–15KApr 20, 2020
49 days late
Katherine M. Clark
MA05 · spouse
BoughtMar 2, 2020$1K–15KApr 20, 2020
49 days late

See a number that looks wrong?